FDC share price has zoomed 6% and is presently trading at Rs 563.0.
Meanwhile, the BSE HEALTHCARE index is at 44,757.8 (up 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 4.0%) and POLY MEDICURE (up 3.8%).
Natco Pharma (down 2.5%) and GLAND PHARMA (down 1.4%) are among the top losers today.
Over the last one year, FDC has moved up from Rs 375.3 to Rs 563.0, registering a gain of Rs 187.7 (up 50.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,152.0 to 44,757.8, registering a gain of 59.0% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 187.4%), Glenmark Pharma (up 132.8%) and SUVEN PHARMACEUTICALS (up 110.1%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 81,850.2 (down 0.1%).
The top losers among the BSE Sensex today are Bajaj Finance (down 1.9%) and M&M (down 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..
In the meantime, NSE Nifty is at 25,071.9 (down 0.2%). Bajaj Auto and Wipro are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,473.1 to 81,850.2, registering a gain of 15,377.2 points (up 23.1%).
FDC net profit grew 8.4% YoY to Rs 1,190 million for the quarter ended June 2024, compared to a profit of Rs 1,098 million a year ago. Net sales rose 19.0% to Rs 6,383 million during the period as against Rs 5,364 million in April-June 2023.
For the year ended March 2024, FDC reported 57.4% increase in net profit to Rs 3,051 million compared to net profit of Rs 1,938 million during FY23. Revenue of the company grew 8.9% to Rs 19,429 million during FY24.
The current Price to earnings ratio of FDC, based on rolling 12 month earnings, stands at 29.2.
Equitymaster requests your view! Post a comment on "FDC Gains 6%; BSE HEALTHCARE Index Up 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!